RecruitingNot ApplicableNCT07657286

Inflammatory Cytokines and Oxidative Stress Biomarkers in Diabetic Chronic Kidney Disease Patients

Inflammatory Cytokines and Oxidative Stress Biomarkers Response to Life Style Modification in Diabetic Chronic Kidney Disease Patients

Sponsor

Badr University

Enrollment

60 participants

Start Date

Jun 7, 2026

Study Type

INTERVENTIONAL

Conditions

Diabetes Chronic Kidney Disease

Summary

This research intends to analyze how a 12-week adjustment in lifestyle influences inflammatory cytokines and oxidative stress indicators in overweight individuals diagnosed with type 2 diabetes and moderate CKD

Eligibility

Min Age: 36 YearsMax Age: 58 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying aerobic treadmill exercises for people with chronic kidney disease and diabetes. The study is currently recruiting participants at 1 location. People eligible for this study include aged 36 Years to 58 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERaerobic treadmill exercises

diet (1200 kcal/day)

Locations(1)

Mona Mohamed Abdelkhalek

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07657286

Related Trials

An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions

NCT062782074 locations

Upstroke Time Measured by Photoplethysmography

NCT057955822 locations